These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 23395662
41. The 1.76 A resolution crystal structure of glycogen phosphorylase B complexed with glucose, and CP320626, a potential antidiabetic drug. Oikonomakos NG, Zographos SE, Skamnaki VT, Archontis G. Bioorg Med Chem; 2002 May; 10(5):1313-9. PubMed ID: 11886794 [Abstract] [Full Text] [Related]
42. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase. Cheng K, Liu J, Sun H, Xie J. Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331 [Abstract] [Full Text] [Related]
43. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity. Wang Y, Yan Z, Guo Y, Zhang L. Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369 [Abstract] [Full Text] [Related]
44. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states. Mitchell EP, Withers SG, Ermert P, Vasella AT, Garman EF, Oikonomakos NG, Johnson LN. Biochemistry; 1996 Jun 11; 35(23):7341-55. PubMed ID: 8652510 [Abstract] [Full Text] [Related]
45. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate. Oikonomakos NG, Tsitsanou KE, Zographos SE, Skamnaki VT, Goldmann S, Bischoff H. Protein Sci; 1999 Oct 11; 8(10):1930-45. PubMed ID: 10548038 [Abstract] [Full Text] [Related]
46. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads. Habash M, Taha MO. Bioorg Med Chem; 2011 Aug 15; 19(16):4746-71. PubMed ID: 21788139 [Abstract] [Full Text] [Related]
47. Natural flavonoids are potent inhibitors of glycogen phosphorylase. Jakobs S, Fridrich D, Hofem S, Pahlke G, Eisenbrand G. Mol Nutr Food Res; 2006 Jan 15; 50(1):52-7. PubMed ID: 16317787 [Abstract] [Full Text] [Related]
48. Kinetic and crystallographic studies of glucopyranosylidene spirothiohydantoin binding to glycogen phosphorylase B. Oikonomakos NG, Skamnaki VT, Osz E, Szilágyi L, Somsák L, Docsa T, Tóth B, Gergely P. Bioorg Med Chem; 2002 Feb 15; 10(2):261-8. PubMed ID: 11741774 [Abstract] [Full Text] [Related]
49. Synthesis and evaluation of 3-anilino-quinoxalinones as glycogen phosphorylase inhibitors. Dudash J, Zhang Y, Moore JB, Look R, Liang Y, Beavers MP, Conway BR, Rybczynski PJ, Demarest KT. Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4790-3. PubMed ID: 16143521 [Abstract] [Full Text] [Related]
50. The binding of C5-alkynyl and alkylfurano[2,3-d]pyrimidine glucopyranonucleosides to glycogen phosphorylase b: synthesis, biochemical and biological assessment. Kantsadi AL, Manta S, Psarra AM, Dimopoulou A, Kiritsis C, Parmenopoulou V, Skamnaki VT, Zoumpoulakis P, Zographos SE, Leonidas DD, Komiotis D. Eur J Med Chem; 2012 Aug 01; 54():740-9. PubMed ID: 22770609 [Abstract] [Full Text] [Related]
51. Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 A resolution. Oikonomakos NG, Chrysina ED, Kosmopoulou MN, Leonidas DD. Biochim Biophys Acta; 2003 Apr 11; 1647(1-2):325-32. PubMed ID: 12686153 [Abstract] [Full Text] [Related]
52. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme. Chen L, Li H, Liu J, Zhang L, Liu H, Jiang H. Bioorg Med Chem; 2007 Nov 01; 15(21):6763-74. PubMed ID: 17719791 [Abstract] [Full Text] [Related]
53. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Onda K, Shiraki R, Ogiyama T, Yokoyama K, Momose K, Katayama N, Orita M, Yamaguchi T, Furutani M, Hamada N, Takeuchi M, Okada M, Ohta M, Tsukamoto S. Bioorg Med Chem; 2008 Dec 01; 16(23):10001-12. PubMed ID: 18952447 [Abstract] [Full Text] [Related]
54. FR258900, a novel glycogen phosphorylase inhibitor isolated from Fungus No. 138354. II. Anti-hyperglycemic effects in diabetic animal models. Furukawa S, Murakami K, Nishikawa M, Nakayama O, Hino M. J Antibiot (Tokyo); 2005 Aug 01; 58(8):503-6. PubMed ID: 16266121 [Abstract] [Full Text] [Related]
55. Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors. Anderka O, Loenze P, Klabunde T, Dreyer MK, Defossa E, Wendt KU, Schmoll D. Biochemistry; 2008 Apr 22; 47(16):4683-91. PubMed ID: 18373353 [Abstract] [Full Text] [Related]
56. Recent advances in the allosteric inhibition of glycogen phosphorylase. Loughlin WA. Mini Rev Med Chem; 2010 Oct 22; 10(12):1139-55. PubMed ID: 20716052 [Abstract] [Full Text] [Related]
57. Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors. Onda K, Shiraki R, Yonetoku Y, Momose K, Katayama N, Orita M, Yamaguchi T, Ohta M, Tsukamoto S. Bioorg Med Chem; 2008 Sep 15; 16(18):8627-34. PubMed ID: 18723356 [Abstract] [Full Text] [Related]
58. Synthesis and biological evaluation of ambradiolic acid as an inhibitor of glycogen phosphorylase. Liu J, Zhang H, Zhu P, Wu X, Yao H, Ye W, Jiang J, Xu J. Fitoterapia; 2015 Jan 15; 100():50-5. PubMed ID: 25447165 [Abstract] [Full Text] [Related]
59. Glycogen phosphorylase a inhibitors with a phenethylphenylphthalimide skeleton derived from thalidomide-related alpha-glucosidase inhibitors and liver X receptor antagonists. Motoshima K, Ishikawa M, Sugita K, Hashimoto Y. Biol Pharm Bull; 2009 Sep 15; 32(9):1618-20. PubMed ID: 19721243 [Abstract] [Full Text] [Related]
60. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents. Zhang L, Jia X, Dong J, Chen D, Liu J, Zhang L, Wen X. Chem Biol Drug Des; 2014 Mar 15; 83(3):297-305. PubMed ID: 24119242 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]